Study on acinetobacter baumannii infection distribution and drug resistance analysis in a hospital during 2012
10.3969/j.issn.1673-4130.2014.05.029
- VernacularTitle:2012年某院鲍曼不动杆菌感染分布及耐药性分析
- Author:
Wei LIU
;
Lujun LI
;
Yun LONG
;
Hongquan CUI
;
Yan WANG
;
Xiaowei LIU
- Publication Type:Journal Article
- Keywords:
acinetobacter baumannii;
drug resistance,microbial;
microbial sensitivity tests
- From:
International Journal of Laboratory Medicine
2014;(5):576-577
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the distribution and drug resistance of 130 clinical strains of acinetobacter (A ) .baumannii in 2012 .Methods The bacterial identification and the susceptibility test were performed by using the micro-organisms identification and susceptibility plate produced by the Zhuhai Deere Company .The data were collected and statistically analyzed by the SPSS 17 .0 software .Results 130 strains of A .baumannii were isolated from 1 391 clinical samples during 2012 ,the detection rate was 9.35% .Thesamplesweremainlyderivedfromsputum(89.23% )andthedepartmentwasmainlydistributedinICU(46.15% ).A. baumannii isolates showed the lowest resistant rates to cefoperazone-sulbactam and polymyxin B ,which were 6 .9% and 7 .7% re-spectively .The drug resistance rate against the third-generation of cephalosporin commonly used in clinic was more than 70% .The resistant rates to imipenem and meropenem were 44 .6% and 58 .5% respectively .The drug resistance rates of A .baumannii isolates to 13 usual antibacterial drugs in ICU were significantly higher than those in non-ICU departments(P<0 .05) .Conclusion The re-sistance of A .baumannii to antibacterial drugs is gradually serious ,which should be paid high attention to in clinic ,and at the same time the comprehensive measures of prevention and control of hospital infection should be adopted to reduce the spread of drug-re-sistant bacteria .
